Mark J. Eisenberg, MD, MPH1,2,3; Andréa Hébert-Losier, MSc1; Sarah B. Windle, MPH1; Todd Greenspoon, MD4; Tim Brandys, MD5; Tamàs Fül?p, MD, PhD6; Thang Nguyen, MD7; Stéphane Elkouri, MD8; Martine Montigny, MD9; Igor Wilderman, MD10; Olivier F. Bertrand, MD, PhD11; Joanna Alexis Bostwick, MD12; John Abrahamson, MD13; Yves Lacasse, MD11; Smita Pakhale, MD14; Josselin Cabaussel, MSc1; Kristian B. Filion, PhD1,2; for the E3 Investigators
doi : 10.1001/jama.2020.18889
JAMA. 2020;324(18):1844-1854
Electronic cigarettes (e-cigarettes) for smoking cessation remain controversial.
Heike A. Bischoff-Ferrari, MD, DrPH1,2,3; Bruno Vellas, MD, PhD4,5; René Rizzoli, MD6; Reto W. Kressig, MD7; José A. P. da Silva, MD, PhD8,9; Michael Blauth, MD10; David T. Felson, MD, MPH11,12; Eugene V. McCloskey, MD13,14; Bernhard Watzl, PhD15; Lorenz C. Hofbauer, MD16,17; Dieter Felsenberg, MD, PhD18; Walter C. Willett, MD19,20; Bess Dawson-Hughes, MD21; JoAnn E. Manson, MD, DrPH22; Uwe Siebert, MD, MPH23,24,25; Robert Theiler, MD2; Hannes B. Staehelin, MD26; Caroline de Godoi Rezende Costa Molino, PhD1; Patricia O. Chocano-Bedoya, MD, PhD1; Lauren A. Abderhalden, PhD1; Andreas Egli, MD1; John A. Kanis, MD27,28; Endel J. Orav, PhD29; for the DO-HEALTH Research Group
doi : 10.1001/jama.2020.16909
JAMA. 2020;324(18):1855-1868
The benefits of vitamin D, omega-3 fatty acids, and exercise in disease prevention remain unclear.
Michael L. Barnett, MD, MS1,2; Karen E. Joynt Maddox, MD, MPH3,4; E. John Orav, PhD1,2; David C. Grabowski, PhD5; Arnold M. Epstein, MD, MA1,2
doi : 10.1001/jama.2020.19181
JAMA. 2020;324(18):1869-1877
Medicare recently concluded a national voluntary payment demonstration, Bundled Payments for Care Improvement (BPCI) model 3, in which skilled nursing facilities (SNFs) assumed accountability for patients’ Medicare spending for 90 days from initial SNF admission. There is little evidence on outcomes associated with this novel payment model.
Mohamad El Moheb, MD1; Leon Naar, MD1; Mathias A. Christensen, BSc1; Carolijn Kapoen, BSc1; Lydia R. Maurer, MD1; Maha Farhat, MD, MSc2; Haytham M. A. Kaafarani, MD, MPH1
doi : 10.1001/jama.2020.19400
JAMA. 2020;324(18):1899-1901
Mario Mali?ki, MD, MA, PhD1; Ana Jeron?i?, MSc, PhD2; Gerben ter Riet, MD, PhD3; Lex M. Bouter, MSc, PhD4; John P. A. Ioannidis, MD, DSc1; Steven N. Goodman, MD, PhD5; IJsbrand Jan Aalbersberg, MSc, PhD6
doi : 10.1001/jama.2020.17195
JAMA. 2020;324(18):1901-1903
Harlan M. Krumholz, MD, SM1; Theodora Bloom, PhD2; Richard Sever, PhD3; Claire Rawlinson, BSc2; John R. Inglis, PhD3; Joseph S. Ross, MD, MHS4
doi : 10.1001/jama.2020.17529
JAMA. 2020;324(18):1903-1905
US Preventive Services Task Force
doi : 10.1001/jama.2020.20122
JAMA. 2020;324(18):1878-1883
Prevalence of hypertension (both primary and secondary) in children and adolescents in the US ranges from 3% to 4%. Primary hypertension in children and adolescents occurs primarily in children older than 13 years and has no known cause but is associated with several risk factors, including family history and higher body mass index. Secondary hypertension occurs primarily in younger children and is most commonly caused by genetic disorders, renal disease, endocrine disorders, or cardiovascular abnormalities.
Gerald Gartlehner, MD, MPH1,2,3; Emily B. Vander Schaaf, MD, MPH1,4; Colin Orr, MD1,4; Sara M. Kennedy, MPH1,2; Rachel Clark, BA1; Meera Viswanathan, PhD1,2
doi : 10.1001/jama.2020.11119
JAMA. 2020;324(18):1884-1895
Childhood hypertension can result in adverse outcomes during adulthood; identifying and treating primary and secondary childhood hypertension may reduce such risks.
Jerome M. Adams, MD, MPH1; Janet S. Wright, MD1
doi : 10.1001/jama.2020.20356
JAMA. 2020;324(18):1825-1826
Christopher W. Seymour, MD, MSc1,2; Erin K. McCreary, PharmD3; Jacob Stegenga, PhD4
doi : 10.1001/jama.2020.20271
JAMA. 2020;324(18):1827-1828
Kristine Olson, MD, MSc1,2; Tait Shanafelt, MD3; Steve Southwick, MD1,4
doi : 10.1001/jama.2020.20275
JAMA. 2020;324(18):1829-1830
Rachel E. Sachs, JD, MPH1; Julie M. Donohue, PhD2; Stacie B. Dusetzina, PhD3
doi : 10.1001/jama.2020.19325
JAMA. 2020;324(18):1831-1832
Carolyn Becker, MD1
doi : 10.1001/jama.2020.21021
JAMA. 2020;324(18):1833-1834
Nancy A. Rigotti, MD1
doi : 10.1001/jama.2020.18967
JAMA. 2020;324(18):1835-1837
Priya Verghese, MD, MPH1; Debora Matossian, MD, MSCI1
doi : 10.1001/jama.2020.21711
JAMA. 2020;324(18):1838-1839
Annette Flanagin, RN, MA1; Phil B. Fontanarosa, MD, MBA1; Howard Bauchner, MD1
doi : 10.1001/jama.2020.20674
JAMA. 2020;324(18):1840-1843
Danielle S. Graham, MD, MBA1; Ronald W. Busuttil, MD, PhD2; Fady M. Kaldas, MD2
doi : 10.1001/jama.2020.15919
JAMA. 2020;324(18):1896-1897
Rita Rubin, MA
doi : 10.1001/jama.2020.21106
JAMA. 2020;324(18):1813-1815
Lawrence O. Gostin, JD1
doi : 10.1001/jama.2020.18347
JAMA. 2020;324(18):1816-1817
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.20804
JAMA. 2020;324(18):1819
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.21129
JAMA. 2020;324(18):1819
Jennifer Abbasi
doi : 10.1001/jama.2020.21627
JAMA. 2020;324(18):1818
Jennifer Abbasi
doi : 10.1001/jama.2020.21073
JAMA. 2020;324(18):1818
Jennifer Abbasi
doi : 10.1001/jama.2020.21628
JAMA. 2020;324(18):1818
Jill Jin, MD, MPH1
doi : 10.1001/jama.2020.19880
JAMA. 2020;324(18):1916
Elio Antonucci, MD1; Manuela Giovini, MD1; Antonio Maria Dell’Anna, MD2
doi : 10.1001/jama.2020.18591
JAMA. 2020;324(18):1905-1906
Bruno L. Ferreyro, MD1; Federico Angriman, MD, MPH1; Damon C. Scales, MD, PhD1
doi : 10.1001/jama.2020.18602
JAMA. 2020;324(18):1906-1907
Jeff Whittle, MD, MPH1
doi : 10.1001/jama.2020.19009
JAMA. 2020;324(18):1907
Jean C. Digitale, MPH, RN1; Thomas B. Newman, MD, MPH1
doi : 10.1001/jama.2020.19012
JAMA. 2020;324(18):1907-1908
Ali Ahmed, MD, MPH1; Wen-Chih Wu, MD2; Charles Faselis, MD1
doi : 10.1001/jama.2020.19015
JAMA. 2020;324(18):1908
Ariela R. Orkaby, MD, MPH1; David R. Gagnon, MD, PhD2; Luc Djousse, MD, ScD2
doi : 10.1001/jama.2020.19018
JAMA. 2020;324(18):1908-1909
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟